CFM
ONCY

Catalyst Funds Management’s Oncolytics Biotech ONCY Stock Holding History

Catalyst Funds Management’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.1K Buy
+31,676
New +$29.4K ﹤0.01% 639

Other funds holding ONCY

Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
SI
Seeds Investor New York $973M AUM 33.7% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

Catalyst Funds Management's ONCY Position: Q2 2026 in Review

Catalyst Funds Management opened a new position in Oncolytics Biotech (ONCY) in Q2 2026: 31,676 shares worth $30.1K. The stake represents ﹤0.01% of the portfolio and ranks #639 among its holdings.

76 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

  • Catalyst Funds Management held 31,676 shares of Oncolytics Biotech worth $30.1K as of Q2 2026.
  • Oncolytics Biotech was a new Catalyst Funds Management position in Q2 2026.
  • Oncolytics Biotech made up ﹤0.01% of Catalyst Funds Management's portfolio in Q2 2026, its #639 holding.
  • 76 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.